| Literature DB >> 34302897 |
Shuting S Cai1, Tianyu Li1, Tolulope Akinade2, Yuefei Zhu1, Kam W Leong3.
Abstract
Design of micro- or nanocarriers for drug delivery has primarily been focused on properties such as hydrophobicity, biodegradability, size, shape, surface charge, and toxicity, so that they can achieve optimal delivery with respect to drug loading, release kinetics, biodistribution, cellular uptake, and biocompatibility. Incorporation of stimulus-sensitive moieties into the carriers would lead to "smart" delivery systems. A further evolution would be to endow the carrier with a therapeutic function such that it no longer serves as a mere passive entity to release the drug at the target tissue but can be viewed as a therapeutic agent in itself. In this review, we will discuss recent and ongoing efforts over the past decade to design therapeutic drug carriers that confer a biological benefit, including ROS scavenging or generating, pro- or anti-inflammatory, and immuno-evasive properties, to enhance the overall therapeutic efficacy of the delivery systems.Entities:
Keywords: Anti-bacterial; Anti-fibrotic; Anti-inflammatory; Anti-microbial; Drug delivery; Immunoadjuvant; ROS generation; ROS scavenging; Therapeutic carriers
Mesh:
Substances:
Year: 2021 PMID: 34302897 PMCID: PMC8440421 DOI: 10.1016/j.addr.2021.113884
Source DB: PubMed Journal: Adv Drug Deliv Rev ISSN: 0169-409X Impact factor: 17.873